Lyn Libertine

Novel Hydrophobically Modified Asymmetric RNAi Compounds (sd-rxRNA) Demonstrate Robust Efficacy in the Eye

Michael Byrne, Radouil Tzekov, Yi Wang et al. · Journal of Ocular Pharmacology and Therapeutics · 2013 · 77 citations

5-Lipoxygenase inhibitors with histamine H 1 receptor antagonist activity

Timothy A. Lewis, Lynn Bayless, Joseph Eckman et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 37 citations · Full text

Biochemistry, Medicine, Mechanism Of Action +5

Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders

Roger B. Clark, Diana Lamppu, Lyn Libertine et al. · Journal of Medicinal Chemistry · 2014 · 33 citations · Full text

Piperazine Scaffold, Inflammatory Lung Disease, Lung Inflammation +20

5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds

Timothy A. Lewis, Lynn Bayless, A.J. Dipesa et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 31 citations · Full text

Medicinal Chemistry, Aldehyde Dehydrogenase, 5-Lipoxygenase Inhibition +6

Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity

Timothy A. Lewis, Michelle Young, Mark P. Arrington et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 10 citations · Full text

5-Lipoxygenase Inhibitory Activity, Medicinal Chemistry, Antiparasitic Agent +6